Published in

Annals of Translational Medicine, 11(6), p. 238-238

DOI: 10.21037/atm.2018.05.40

Links

Tools

Export citation

Search in Google Scholar

Is there a place for the combination of brentuximab vedotin and bendamustine in treatment of patients with relapsed/refractory Hodgkin lymphoma?

Journal article published in 2018 by Robert W. Chen
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload